Financhill
Sell
38

XENE Quote, Financials, Valuation and Earnings

Last price:
$38.64
Seasonality move :
18.17%
Day range:
$38.00 - $39.46
52-week range:
$35.53 - $50.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
222.63x
P/B ratio:
3.70x
Volume:
850.2K
Avg. volume:
423.9K
1-year change:
-5.63%
Market cap:
$2.9B
Revenue:
--
EPS (TTM):
-$2.82

Earnings Data

Next earnings date for XENE
Feb 28
2025
Most recent earnings per share
-$0.81
Missed by $0.02
(Nov 12/2024)
Consensus Estimate
-$0.79
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

XENE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/28/2025 Q4 $312.5K -- -- -$0.84 --
11/12/2024 Q3 -- -- -$0.81 -$0.79 -$0.02
08/08/2024 Q2 -- -- -$0.75 -$0.68 -$0.07
05/09/2024 Q1 -- -- -$0.62 -$0.65 $0.03
02/29/2024 Q4 $2M -- -$0.64 -$0.76 $0.12
11/08/2023 Q3 -- -- -$0.73 -$0.75 $0.02
08/09/2023 Q2 -- -- -$0.72 -$0.67 -$0.05
05/09/2023 Q1 -- -- -$0.63 -$0.60 -$0.03
03/01/2023 Q4 -- -- -$0.57 -$0.59 $0.02
11/08/2022 Q3 -- -- -$0.57 -$0.53 -$0.04
08/09/2022 Q2 -- -- -$0.55 -$0.50 -$0.05
05/10/2022 Q1 -- -- -$0.35 -- --
03/01/2022 Q4 -- -- -$0.48 -- --
11/10/2021 Q3 -- -- -$0.36 -- --
08/11/2021 Q2 -- -- -$0.51 -- --
05/11/2021 Q1 -- -- -$0.42 -- --
03/01/2021 Q4 -- -- -$0.34 -- --
11/05/2020 Q3 -- -- -$0.25 -- --
08/06/2020 Q2 -- -- -$0.00 -- --
05/21/2020 Q1 -- -- -$0.22 -- --
03/09/2020 Q4 -- -- -$0.41 -- --
11/05/2019 Q3 -- -- -$0.33 -- --
08/06/2019 Q2 -- -- -$0.37 -- --
05/07/2019 Q1 -- -- -$0.42 -- --
03/06/2019 Q4 -- -- -$0.29 -- --
11/06/2018 Q3 -- -- -$0.63 -- --
08/07/2018 Q2 -- -- -$0.45 -- --
05/08/2018 Q1 -- -- -$0.21 -- --
03/07/2018 Q4 -- -- -$0.45 -- --
11/07/2017 Q3 -- -- -$0.43 -- --
08/03/2017 Q2 -- -- -$0.41 -- --
05/09/2017 Q1 -- -- -$0.43 -- --
03/08/2017 Q4 -- -- -$0.32 -- --
11/03/2016 Q3 -- -- -$0.51 -- --
08/03/2016 Q2 -- -- -$0.42 -- --
05/10/2016 Q1 -- -- -$0.23 -- --
03/08/2016 Q4 -- -- -$0.27 -- --
11/10/2015 Q3 -- -- -$0.27 -- --
08/10/2015 Q2 -- -- -$0.07 -- --
05/12/2015 Q1 -- -- -$0.64 -- --
03/12/2015 Q4 -- -- $0.66 -- --

Xenon Pharmaceuticals Earnings Questions

  • How Much did Xenon Pharmaceuticals Generate in Revenue Last Quarter?

    Xenon Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Xenon Pharmaceuticals Beat Earnings Last Quarter?

    Xenon Pharmaceuticals announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.79 per share.

  • Is Xenon Pharmaceuticals Profitable?

    Xenon Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Xenon Pharmaceuticals EPS Next Year?

    Xenon Pharmaceuticals's earnings are forecast to decrease from -$2.73 per share to -$2.82 per share next year representing a decrease of -12.94%.

  • When is Xenon Pharmaceuticals's Earnings Date?

    Xenon Pharmaceuticals's next earnings date is February 28, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock